MFT says hormone blood test can determine efficacy of breast cancer drug anastrozole
As per the findings of the research, up to 25% of post-menopausal women at high risk of developing…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Mar 24
As per the findings of the research, up to 25% of post-menopausal women at high risk of developing…
02 Feb 24
DELFI-TF is a research-use-only test designed for low-cost and non-invasive measurement of tumour burden along with the evaluation…
17 Jan 24
Lunit will provide Samsung Electronics with Lunit INSIGHT CXR, an AI-powered chest X-ray analysis solution that can detect…
22 Dec 23
The quantitative immunoassay, which is said to have high sensitivity and specificity, is designed to detect aPAP GM-CSF…
21 Dec 23
The assay is intended to be used for the quantitative urine-based diagnosis of bladder cancer and upper tract…
20 Dec 23
The Calprotectin Immunoturbidimetric Assay is authorised in the US for in vitro diagnostic use to diagnose inflammatory bowel…
19 Dec 23
The collaboration has resulted in a clinical feasibility trial of GRIP Molecular Technologies’ patented electronic biosensor technology which…
13 Dec 23
The objectives of the study include assessing the Freenome's test's sensitivity, specificity, positive and negative predictive values in…
12 Dec 23
The new screening method is designed to use antigens to evaluate multiple disease markers, assess several samples simultaneously,…
21 Nov 23
The trial is intended to assess and compare the group of Medicare beneficiaries who undergo standard care along…